Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002011 · ClinicalTrials.gov registry record · NA

The Therakos UVAR Photopheresis System in the Treatment of AIDS-Related Complex

A NA study of HIV Infections, sponsored by Therakos.

Completed
Registry status
NA
Development phase
1
Study location

NCT00002011: Completed NA study of HIV Infections, sponsored by Therakos.

NCT00002011 is a NA study of HIV Infections that has completed, run by Therakos. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002011, a NA study of HIV Infections, has completed, sponsored by Therakos.

COMPLETED
Registry status
NA
Development phase
1
Study location

Study Summary

To determine the safety and patient tolerance of UVAR Photopheresis System (extracorporeal photopheresis) in the Treatment of AIDS-Related Complex (ARC).

Conditions Studied

Interventions

  • DRUG Methoxsalen

Study Locations (1)

New Jersey

  • Morristown Memorial Hosp - Morristown

Trial Details

FieldValue
Phase NA
Therakos

1 total trials

What the finished NCT00002011 record still lists

NCT00002011 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Methoxsalen is the first listed.

NCT00002011 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT00002011 about?

NCT00002011 is a clinical study titled "The Therakos UVAR Photopheresis System in the Treatment of AIDS-Related Complex". To determine the safety and patient tolerance of UVAR Photopheresis System (extracorporeal photopheresis) in the Treatment of AIDS-Related Complex (ARC).

What is the current status of trial NCT00002011?

This trial is currently completed. It is a NA study.

What conditions does trial NCT00002011 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT00002011?

The interventions under investigation include: Methoxsalen (DRUG).

Who is sponsoring clinical trial NCT00002011?

This trial is sponsored by Therakos, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002011 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Source: ClinicalTrials.gov NCT00002011, the US trial registry maintained by the National Library of Medicine. NCT00002011 (unsized enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.